Randomized Clinical Trials and Public Interest. How Politics Precedes Bioethics

Authors

  • David Teira Serrano Dpto. de Lógica, Historia y Filosofía de la Ciencia UNED. Humanidades

DOI:

https://doi.org/10.3989/arbor.2008.i730.173

Keywords:

randomization, clinical trials, bioethics, British health policy

Abstract


This paper analyses the normative justification of the adoption of randomized clinical trials as a methodological standard for pharmaceutical policy by the British health authorities in 1946. Through a discussion of the interests of the different parties involved in the process (doctors, patients, pharmaceutical companies and the State) I argue that randomization was adopted namely as an impartial mechanism to allocate treatments, even if its statistical foundations were not properly understood. I contend that such justification is still valid.

Downloads

Download data is not yet available.

Author Biography

David Teira Serrano, Dpto. de Lógica, Historia y Filosofía de la Ciencia UNED. Humanidades

References

Abraham J. (1995): Science, Politics and the Pharmaceutical Industry, St. Martin’s Press, N. York.

Bardswell, N. D. y Thompson, J. H. R. (1919): Pulmonary Tuberculosis: Mortality after a Sanatorium Treatment, HMSO, Londres.

Beveridge, W. (1942): Social Insurance and Allied Aervices, HMSO, Londres.

Cox-Maksimov, D. (1997) The Making of the Clinical Trial in Britain, 1910-1945: Expertise, the State and the Public, Tesis doctoral inédita, Universidad de Cambridge.

Elster, J. (1988): Taming Chance: Randomization in Individual and Social Decisions, University of Utah Press, Salt Lake City.

Epstein, S. (1996): Impure Science. Aids and the Politics of Knowledge, University of California Press, Berkeley-Los Angeles.

García Alonso, M. y Teira, D. (2006): “Normas éticas y estadísticas en la justificación de los ensayos clínicos aleatorizados”, Crítica: 38, 39-60.

Ham, C. (1988): Health Policy in Britain, MacMillan, Londres.

Levine, R. J. (1988): Ethics and Regulation of Clinical Research, Yale University Press, New Haven-Londres.

Marks, H. M. (1997): The Progress of Experiment. Science and Therapeutic Reform in the United States, 1900-1990, Cambridge University Press, N. York.

Timmermans, S. y Berg, M. (2003): The Gold Standard. The Challenge of Evidence-Based Medicine and Standardization in Health-Care, Temple University Press, Philadelphia.

Toth, B. (1998): Clinical Trials in British Medicine 1858-1948, with Special Reference to the Development of the Randomised Controlled Trial, Tesis doctoral inédita, Universidad de Bristol, 1998.

Yoshioka, A. (1998): Streptomycin, 1946: British Central Administration of Supplies of a New Drug of American Origin with Special Reference to Clinical Trials in Tuberculosis, Tesis doctoral inédita, Universidad de Londres.

Downloads

Published

2008-04-30

How to Cite

Teira Serrano, D. (2008). Randomized Clinical Trials and Public Interest. How Politics Precedes Bioethics. Arbor, 184(730), 207–216. https://doi.org/10.3989/arbor.2008.i730.173

Issue

Section

Articles